静脉拉贝洛尔与口服硝苯地平治疗妊娠期急性高血压对脑灌注压的影响
这项前瞻性队列研究纳入16例孕24至42周的重度高血压孕妇,8例接受静脉拉贝洛尔、8例接受口服硝苯地平,给药30分钟后硝苯地平组收缩压、平均动脉压及脑灌注压下降幅度均显著大于拉贝洛尔组,舒张压及大脑中动脉流速变化无显著差异。
要点
- 口服硝苯地平组给药30分钟后脑灌注压下降27.7 mm Hg,拉贝洛尔组仅下降2.5 mm Hg(P=.01)。
- 硝苯地平组收缩压下降39 mm Hg、平均动脉压下降22.3 mm Hg,均显著大于拉贝洛尔组。
- 两组大脑中动脉流速变化无显著差异(0.07 cm/s vs 0.16 cm/s;P=.64)。
核心结论
- 在子痫前期合并急性重度高血压的孕妇中,口服硝苯地平给药后脑灌注压显著下降,而静脉拉贝洛尔未出现显著下降。
- 脑灌注压的下降似乎由外周动脉血压下降驱动,而非脑血流直接改变。
研究设计与样本
- 前瞻性队列研究,纳入孕24至42周、收缩压≥160 mm Hg和/或舒张压≥110 mm Hg的孕妇。
- 共16例入组,8例接受静脉拉贝洛尔,8例接受口服硝苯地平。
- 排除标准包括活跃产程或初始脑灌注压测量前2小时内使用过任何降压药。
- 在给药前及给药后30分钟分别进行外周血压测量和经颅多普勒大脑中动脉血流动力学检查。
主要发现
- 两组基线特征包括产妇年龄、种族和民族、支付方式、医院站点、体重指数、初产、孕周、孕前糖尿病或慢性高血压、胎儿生长受限、硫酸镁使用及症状学均无显著差异(P>.05)。
- 给药30分钟后,硝苯地平组收缩压下降39 mm Hg vs 拉贝洛尔组下降9.8 mm Hg(P=.003),硝苯地平组降幅更大。
- 给药30分钟后,硝苯地平组平均动脉压下降22.3 mm Hg vs 拉贝洛尔组下降7.1 mm Hg(P=.02),硝苯地平组降幅更大。
- 给药30分钟后,硝苯地平组脑灌注压下降27.7 mm Hg vs 拉贝洛尔组下降2.5 mm Hg(P=.01),硝苯地平组降幅更大。
- 舒张压变化(拉贝洛尔组-12.9 mm Hg vs 硝苯地平组-5.4 mm Hg;P=.15)及大脑中动脉流速变化(拉贝洛尔组0.07 cm/s vs 硝苯地平组0.16 cm/s;P=.64)均无统计学显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pregnant women with preeclampsia have been found to have elevated cerebral perfusion pressure and impaired cerebral autoregulation compared with normal pregnant women. Transcranial Doppler is a noninvasive technique used to estimate cerebral perfusion pressure. The effects of different antihypertensive medications on cerebral perfusion pressure in preeclampsia are unknown. OBJECTIVE: To compare the change in cerebral perfusion pressure before and after intravenous labetalol vs oral nifedipine in the setting of acute severe hypertension in pregnancy. STUDY DESIGN: This is a prospective cohort study of pregnant women between 24 and 42 weeks' gestation with severe hypertension (systolic blood pressure ≥160 mm Hg and/or diastolic blood pressure ≥110 mm Hg). Women who consented to the study and received either intravenous labetalol or oral nifedipine were included. Exclusion criteria included active labor or receipt of any antihypertensive medication within 2 hours of initial cerebral perfusion pressure measurement. Peripheral blood pressure and transcranial Doppler studies for middle cerebral artery hemodynamics were performed prior to the administration of antihypertensive medications and repeated 30 minutes after medication administration. RESULTS: A total of 16 women with acute severe hypertension were enrolled; 8 received intravenous labetalol and 8 received oral nifedipine. There were no significant differences between the labetalol and nifedipine groups in baseline characteristics such as maternal age, race and ethnicity, payment, hospital site, body mass index, nulliparity, gestational age, preexisting diabetes mellitus or chronic hypertension, fetal growth restriction, magnesium sulfate administration, and symptomatology (P>.05). When examined 30 minutes after the administration of either intravenous labetalol or oral nifedipine, there was a significantly greater decrease in systolic blood pressure (-9.8 mm Hg vs -39 mm Hg; P=.003), mean arterial pressure (-7.1 mm Hg vs -22.3 mm Hg; P=.02), and cerebral perfusion pressure (-2.5 mm Hg vs -27.7 mm Hg; P=.01) in the nifedipine group. There was no statistically significant decrease in diastolic blood pressure (-12.9 mm Hg vs -5.4 mm Hg; P=.15). The change in middle cerebral artery velocity by transcranial Doppler was compared between the groups and was not different (0.07 cm/s vs 0.16 cm/s; P=.64). CONCLUSION: Oral nifedipine resulted in a significant decrease in cerebral perfusion pressure, whereas labetalol did not, after administration for acute severe hypertension among women with preeclampsia. This decrease seems to be driven by a decrease in peripheral arterial blood pressure rather than a direct change in cerebral blood flow.
引用
- Tolcher MC, Fox KA, Sangi-Haghpeykar H, et al. Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure. Am J Obstet Gynecol. 2020. PMID: 32544404. doi:10.1016/j.ajog.2020.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。